Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers

NCT07184502 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ZT003
DRUG: ZT003
DRUG: Placebo

Sponsor

Beijing QL Biopharmaceutical Co.,Ltd